転移性腎細胞癌:グローバル臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 9
Metastatic Renal Cell Carcinoma 9
Report Guidance 9
Clinical Trials by Region 10
Clinical Trials and Average Enrollment by Country 11
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 13
Top Five Countries Contributing to Clinical Trials in Europe 14
Top Countries Contributing to Clinical Trials in North America 15
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 16
Top Five Countries Contributing to Clinical Trials in Central and South America 17
Clinical Trials by G7 Countries: Proportion of Metastatic Renal Cell Carcinoma to Oncology Clinical Trials 18
Clinical Trials by Phase in G7 Countries 19
Clinical Trials in G7 Countries by Trial Status 20
Clinical Trials by E7 Countries: Proportion of Metastatic Renal Cell Carcinoma to Oncology Clinical Trials 21
Clinical Trials by Phase in E7 Countries 22
Clinical Trials in E7 Countries by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 27
Unaccomplished Trials of Metastatic Renal Cell Carcinoma 28
Subjects Recruited Over a Period of Time 34
Clinical Trials by Sponsor Type 35
Prominent Sponsors 36
Top Companies Participating in Metastatic Renal Cell Carcinoma Therapeutics Clinical Trials 37
Prominent Drugs 39
Latest Clinical Trials News on Metastatic Renal Cell Carcinoma 40
Jan 14, 2014: Rexahn Initiates Phase IIa Clinical Trial of Archexin in Patients with Metastatic Renal Cell Carcinoma 40
Dec 19, 2013: NewLink Genetics Launches Phase 1 Clinical Trial of Its HyperAcute Renal Immunotherapy in Patients With Metastatic Renal Cell Cancer 41
Oct 22, 2013: Curis and Debiopharm Announce Initiation of Phase I Dose Finding Clinical Study With a Combination of HSP90 Inhibitor Debio 0932 and Everolimus 41
Sep 24, 2013: Argos Therapeutics Announces Globalization of Pivotal Phase 3 ADAPT Study for Personalized Cancer Immunotherapy 42
Sep 23, 2013: TRACON Pharmaceuticals Initiates Phase 1b Study of TRC105 in Patients With Metastatic Renal Cell Carcinoma 43
Clinical Trial Profiles 44
Clinical Trial Overview of Top Companies 44
Pfizer Inc. 44
Clinical Trial Overview of Pfizer Inc. 44
Novartis AG 48
Clinical Trial Overview of Novartis AG 48
Bayer AG 51
Clinical Trial Overview of Bayer AG 51
F. Hoffmann-La Roche Ltd. 53
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 53
GlaxoSmithKline plc 55
Clinical Trial Overview of GlaxoSmithKline plc 55
Bristol-Myers Squibb Company 57
Clinical Trial Overview of Bristol-Myers Squibb Company 57
AstraZeneca PLC 58
Clinical Trial Overview of AstraZeneca PLC 58
Eli Lilly and Company 59
Clinical Trial Overview of Eli Lilly and Company 59
iOMEDICO AG 60
Clinical Trial Overview of iOMEDICO AG 60
Amgen Inc. 61
Clinical Trial Overview of Amgen Inc. 61
Clinical Trial Overview of Top Institutes / Government 62
National Cancer Institute 62
Clinical Trial Overview of National Cancer Institute 62
The University of Texas M. D. Anderson Cancer Center 67
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 67
Memorial Sloan Kettering Cancer Center 68
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 68
The University of Chicago 69
Clinical Trial Overview of The University of Chicago 69
Case Comprehensive Cancer Center 70
Clinical Trial Overview of Case Comprehensive Cancer Center 70
UCLA’s Jonsson Comprehensive Cancer Center 71
Clinical Trial Overview of UCLA’s Jonsson Comprehensive Cancer Center 71
University of California, San Francisco 72
Clinical Trial Overview of University of California, San Francisco 72
Radboud University 73
Clinical Trial Overview of Radboud University 73
European Organization for Research and Treatment of Cancer 74
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 74
Roswell Park Cancer Institute 75
Clinical Trial Overview of Roswell Park Cancer Institute 75
Five Key Clinical Profiles 76
Appendix 198
Abbreviations 198
Definitions 198
Research Methodology 199
Secondary Research 199
About GlobalData 200
Contact Us 200
Disclaimer 200
Source 201


【レポート販売概要】

■ タイトル:転移性腎細胞癌:グローバル臨床試験レビュー(2014年上半期)
■ 英文:Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014
■ 発行日:2014年4月15日
■ 調査会社:GlobalData
■ 商品コード:GDHC2075CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。